Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

More research needed to confirm finasteride as standard treatment for FFA.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

IsoPSA test works accurately even if patients take certain prostate medications.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The FDA approved a new Pfizer drug for hair loss in teens.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Finasteride may reduce prostate cancer risk.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Finasteride reduces bleeding during prostate surgery.